KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Change in Receivables (2018 - 2025)

Historic Change in Receivables for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to -$260000.0.

  • ClearPoint Neuro's Change in Receivables fell 16483.79% to -$260000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $552000.0, marking a year-over-year decrease of 5750.58%. This contributed to the annual value of $1.2 million for FY2024, which is 3314.86% down from last year.
  • Latest data reveals that ClearPoint Neuro reported Change in Receivables of -$260000.0 as of Q3 2025, which was down 16483.79% from $609000.0 recorded in Q2 2025.
  • In the past 5 years, ClearPoint Neuro's Change in Receivables ranged from a high of $1.2 million in Q2 2022 and a low of -$846000.0 during Q1 2024
  • Moreover, its 5-year median value for Change in Receivables was $184000.0 (2023), whereas its average is $178000.0.
  • As far as peak fluctuations go, ClearPoint Neuro's Change in Receivables skyrocketed by 48947.37% in 2023, and later crashed by 55978.26% in 2024.
  • ClearPoint Neuro's Change in Receivables (Quarter) stood at -$190000.0 in 2021, then tumbled by 305.79% to -$771000.0 in 2022, then surged by 248.12% to $1.1 million in 2023, then decreased by 8.14% to $1.0 million in 2024, then plummeted by 124.79% to -$260000.0 in 2025.
  • Its Change in Receivables stands at -$260000.0 for Q3 2025, versus $609000.0 for Q2 2025 and -$846000.0 for Q1 2025.